|
 |
| On the cover: In recent years, driven by the new round of scientific and technological revolution coupled with carbon neutrality, the energy structure is undergoing unprecedented changes. Biomass energy can be obtained from abundant resources by a number of application ways, which is zero-carbon and has unique effect of carbon negative emission. Meanwhile, advanced conversion technologies, such as BECCS, pyrolysis, and biohydrogen, are also joining the way to make a better bioenergy. Clean products of biomass have been promoted to a prospective future. Combination of biomass energy development and advanced technology will realize a more flexible and imaginative use of biomass, contributing to a green, low-carbon and sustainable development. For a bright and recyclable future, we should improve the use of biomass energy and unlock its huge potential for energy conservation and carbon reduction. |
|
|
| Add comment (English only) |
|
|
|
|
|
| Position: Home > issue > May 15, 2023 Volume 4, Issue 3 |
|
|
|
| Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study |
Category: Article Download:  PDF  Figure  Endnote |
| Author: Huijuan Zhong,Shu Cheng,Xi Zhang,Bing Xu,Jiayi Chen,Xufeng Jiang,Jie Xiong,Yu Hu,Guohui Cui,Juying Wei,Wenbin Qian,Xiaobing Huang,Ming Hou,Feng Yan,Xin Wang,Yongping Song,Jianda Hu,Yuanhua Liu,Xuejun Ma,Fei Li,Chongyang Wu,Junmin Chen et al. |
|
|
GRAPHICAL ABSTRACT
Methotrexate, etoposide, dexamethasone, and pegaspargase (MESA) with sandwiched radiotherapy is known to be effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type (NKTCL). We explored the efficacy and safety of reduced-intensity, non-intravenous etoposide, dexamethasone, and pegaspargase (ESA) with sandwiched radiotherapy. This multicenter, randomized, phase III trial enrolled patients aged between 14 and 70 years with newly diagnosed early-stage nasal NKTCL from 27 centers in China.
|
|
|
|
TheInnovation´´ÐÂ
TheInnovation´´ÐÂ
The_Innovation
office@the-innovation.org
Official£º